Cambridge Investment Research Advisors
NGVT icon

Cambridge Investment Research Advisors’s Ingevity NGVT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,820
Closed -$273K – 3253
2023
Q1 		$273K Buy
+3,820
New +$303K ﹤0.01% 2568

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICP
Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
BBCM
Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Cambridge Investment Research Advisors's NGVT Position: Q2 2023 in Review

Cambridge Investment Research Advisors sold out of Ingevity (NGVT) in Q2 2023, closing a stake of 3,820 shares — an estimated $273K sold.

Cambridge Investment Research Advisors first reported a position in NGVT in Q1 2023 and held it in 1 quarter. The position peaked at $273K in Q1 2023. 251 funds tracked by Wall St. Rank hold NGVT as of Q2 2023.

  • Cambridge Investment Research Advisors reported no remaining Ingevity position as of Q2 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 3,820 Ingevity shares in Q2 2023, an estimated $273K.
  • Cambridge Investment Research Advisors first reported a position in Ingevity in Q1 2023 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Ingevity position peaked at $273K in Q1 2023.
  • 251 funds tracked by Wall St. Rank held Ingevity as of Q2 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.